|Place of Origin:||China|
|Model Number:||200mg/5ml, 60ml Bottle, 100ml Bottle|
|Minimum Order Quantity:||100, 000 bottles|
|Packaging Details:||one bottle/box|
|Payment Terms:||L/C, T/T|
|Supply Ability:||100, 000 bottles per day|
|Product:||Azithromycin Oral Suspension||Specification:||200mg/5ml, 60ml Bottle, 100ml Bottle|
|Standard:||BP, USP||Packing:||One Bottle/box|
Azithromycin oral Suspension 200mg/5ml, 60ml Bottle, 100ml Bottle Oral Medications Dry Syrup
Product : Azithromycin oral Suspension
Specification : 200mg/5ml, 60ml Bottle, 100ml Bottle
Standard : BP, USP
Packing : one bottle/box
Azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. Like other macrolide antibiotics, azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of the bacterial 70S ribosome. Binding inhibits peptidyl transferase activity and interferes with amino acid translocation during the process of translation. Its effects may be bacteriostatic or bactericidal depending of the organism and the drug concentration. Its long half life, which enables once daily dosing and shorter administration durations, is a property distinct from other macrolides.
For the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions: H. influenzae, M. catarrhalis, S. pneumoniae, C. pneumoniae, M. pneumoniae, S. pyogenes, S. aureus, S. agal
Azithromycin, a semisynthetic antibiotic belonging to the macrolide subgroup of azalides, is used to treat STDs due to chlamydia and gonorrhea, community-acquired pneumonia, pelvic inflammatory disease, pediatric otitis media and pharyngitis, and Mycobacterium avium complex (MAC) in patients with advanced HIV disease. Similar in structure to erythromycin. azithromycin reaches higher intracellular concentrations than erythromycin, increasing its efficacy and duration of action.
Mechanism of action
Azithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.